# Mutuelles Impact

> Mutuelles Impact is a VC fund backing Health Care, Medical Device and Software. See 19 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 19
- Last investment: May 2026
- Lead investor: 42%
- Last updated: Aug 2026
- Website: https://www.mutuellesimpact.fr/

Mutuelles Impact is a VC fund focused on Health Care and Medical Device. Mutuelles Impact Initiated by the Mutualité Française and financed by 45 mutuals and the Mutualité Française, the Mutuelles Impact fund aims to invest and develop companies with a high social impact in the sectors of prevention, care pathways, and medico-social.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.3M–$15M |
| Series B | $14M–$28M |
| Venture - Series Unknown | $3.6M–$25M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 12 | 63% |
| Medical Device | 6 | 32% |
| Software | 4 | 21% |
| Wellness | 4 | 21% |
| Medical | 3 | 16% |

24 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 7 | 37% |
| Venture - Series Unknown | 4 | 21% |
| Series B | 2 | 11% |
| Funding Round | 2 | 11% |
| Series A | 1 | 5% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 14 | 74% |
| Germany | 1 | 5% |
| Switzerland | 1 | 5% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Semeia | Semeia provides software that helps in medical follow-up and consultation. | $24.7M | Venture - Series Unknown | May 11, 2026 |  |
| Mindday | Mindday is reinventing mental well-being by combining human support, digital programs and science to provide immediate and personalized support to anyone. | $2.3M | Seed | Mar 24, 2026 |  |
| Lifeaz | Lifeaz saves lives by developing a new generation of connected, simpler, more reliable and smarter defibrillators. | $15.4M | Seed | Feb 12, 2026 |  |
| Wandercraft | Wandercraft develops autonomous walking exoskeletons and robotic systems designed to restore upright mobility to individuals with walking impairments. The company offers devices such as Atalante X, a hands‑free, self‑balancing exoskeleton used in rehabilitation centers, and a Personal Exoskeleton prototype that leverages AI‑driven balance tosupport walking in daily life. Their systems incorporate real‑time adaptive gait algorithms and powered joints to facilitate multidirectional movement and support early intensive rehabilitation. Wandercraft collaborates with healthcare institutions and has initiated clinical trials to evaluate safety and effectiveness in managing spinal cord injuries and stroke rehabilitation. | $75M | Series D | Jun 06, 2025 |  |
| Ensweet | Ensweet is a telemedicine platform intended to offer telerehabilitation services to patients. They offer equipment so that everyone can exercise whenever possible, enabling patients to have accessible rehabilitation. | $3.4M | Seed | May 20, 2025 |  |
| Diagnoly | Diagnoly develops an AI-powered medical plug-in device that analyzes fetal examination in real-time and helps doctors to detect the most complex fetal pathologies. | $6M | Seed | Apr 08, 2025 |  |
| HelloBetter | HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services. | $6.5M | Venture - Series Unknown | Mar 05, 2025 |  |
| Lyv | Lyv helps people sufferin | $2.7M | Seed | Feb 04, 2025 |  |
| SURGAR | SURGAR provides a plug-and-play augmented reality software suite for computer-aided laparoscopic surgery. | $12.3M | Venture - Series Unknown | Sep 26, 2024 |  |
| SamanTree Medical | SamanTree Medical is a swiss innovative medical device company providing a breakthrough imaging solution with the potential to improve patient care and cancer surgery outcome. Based on confocal microscopy, SamanTree Medical’s solution brings accurate and full margin control by the surgeon, in the operating room. | $14M | Series B | Jul 16, 2024 |  |

10 of 19 investments shown.

## Co-investors
- [XAnge](https://shizune.co/investors/profile/xange-private-equity) — VC Fund, 15 deals together
- [Impactivist](https://shizune.co/investors/profile/investir) — VC Fund, 4 deals together
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 2 deals together
- [Cemag Invest](https://shizune.co/investors/profile/cemag-invest) — VC Fund, 2 deals together
- [LBO France](https://shizune.co/investors/profile/lbo-france) — VC Fund, 2 deals together
- [MACSF](https://shizune.co/investors/profile/macsf) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Health Care Investors in France](https://shizune.co/investors/health-care-investors-france)
- [Health Care VC Funds in France](https://shizune.co/investors/health-care-vc-funds-france)
- [Wellness Investors in France](https://shizune.co/investors/wellness-investors-france)
- [Medical Device Investors in France](https://shizune.co/investors/medical-device-investors-france)
- [Fitness VC Funds in France](https://shizune.co/investors/fitness-vc-funds-france)

## FAQ

### What does Mutuelles Impact invest in?

Mutuelles Impact invests primarily in Health Care, Medical Device and Software startups, most often at Seed and Venture - Series Unknown stage. Most of the 19 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Mutuelles Impact's check size?

Mutuelles Impact typically joins rounds of $2.3M–$15M at Seed, $14M–$28M at Series B and $3.6M–$25M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Mutuelles Impact participates in.

### When did Mutuelles Impact last invest?

The most recent investment recorded for Mutuelles Impact closed in May 2026. Shizune tracks 19 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co